Insiders / Cabell Christopher

Cabell Christopher

CIK 1814928personinsider
Companies
1
First seen
Jan 7, 2026
Last activity
Feb 24, 2026

Companies

1View all →
CompanyRoleShares heldPeak heldTradesLatest
Inhibikase Therapeutics, Inc. · IKTExecutive676,564900,1172—

All securities held

2 positions · latest reported per filing
CompanySecuritySharesAs of
Inhibikase Therapeutics, Inc.Common Stock676,564Feb 21, 2026
Inhibikase Therapeutics, Inc.Stock Option (Right to Buy)Derivative900,117Jan 5, 2026

Activity

View all →
InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Feb 21, 2026OtherIKT
Inhibikase Therapeutics, Inc.
Common Stock
$0-338K
-33.33%
676,564
0.48% of shares
low
Jan 5, 2026GrantIKT
Inhibikase Therapeutics, Inc.
Stock Option (Right to Buy)
—+900K
900,117
0.65% of shares
low